Selected research
Industry Research
Pipeline Embolization Device (PED) Industry Research Report 2026
Market perspective
The global Pipeline Embolization Device (PED) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pipeline Embolization Device (PED) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pipeline Embolization Device (PED) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pipeline Embolization Device (PED) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pipeline Embolization Device (PED) include Ascendis Health, Balt Extrusion, Boston Scientific, Codman, Evasc, Microvention, Phenox GmbH, Accumedical and ZYLOX-TONBRIDGE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pipeline Embolization Device (PED) market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pipeline Embolization Device (PED) Market by Company
Ascendis Health
Balt Extrusion
Boston Scientific
Codman
Evasc
Microvention
Phenox GmbH
Accumedical
ZYLOX-TONBRIDGE
Medtronic
Johnson & Johnson
Stryker Corporation
MicroPort
Pipeline Embolization Device (PED) Segment by Type
48 Alloy Wire Braided
64 Alloy Wire Braided
Other
Pipeline Embolization Device (PED) Segment by Application
Intracranial Aneurysm Treatment
Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)
Other
Pipeline Embolization Device (PED) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pipeline Embolization Device (PED) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pipeline Embolization Device (PED) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pipeline Embolization Device (PED).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pipeline Embolization Device (PED) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pipeline Embolization Device (PED) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pipeline Embolization Device (PED) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 48 Alloy Wire Braided
- 64 Alloy Wire Braided
- Other
Applications
- Intracranial Aneurysm Treatment
- Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)
- Other
Companies covered
- Ascendis Health
- Balt Extrusion
- Boston Scientific
- Codman
- Evasc
- Microvention
- Phenox GmbH
- Accumedical
- ZYLOX-TONBRIDGE
- Medtronic
- Johnson & Johnson
- Stryker Corporation
- MicroPort
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pipeline Embolization Device (PED) Market Size (2021-2032)
- 2.2.2 Global Pipeline Embolization Device (PED) Sales (2021-2032)
- 2.2.3 Global Pipeline Embolization Device (PED) Market Average Price (2021-2032)
- 2.3 Pipeline Embolization Device (PED) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 48 Alloy Wire Braided
- 2.3.3 64 Alloy Wire Braided
- 2.3.4 Other
- 2.4 Pipeline Embolization Device (PED) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Intracranial Aneurysm Treatment
- 2.4.3 Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pipeline Embolization Device (PED) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pipeline Embolization Device (PED) Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Pipeline Embolization Device (PED) Revenue of Manufacturers (2021-2026)
- 3.4 Global Pipeline Embolization Device (PED) Average Price by Manufacturers (2021-2026)
- 3.5 Global Pipeline Embolization Device (PED) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pipeline Embolization Device (PED), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pipeline Embolization Device (PED), Product Type & Application
- 3.8 Global Manufacturers of Pipeline Embolization Device (PED), Established Date
- 3.9 Global Pipeline Embolization Device (PED) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ascendis Health
- 4.1.1 Ascendis Health Company Information
- 4.1.2 Ascendis Health Business Overview
- 4.1.3 Ascendis Health Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Ascendis Health Pipeline Embolization Device (PED) Product Portfolio
- 4.1.5 Ascendis Health Recent Developments
- 4.2 Balt Extrusion
- 4.2.1 Balt Extrusion Company Information
- 4.2.2 Balt Extrusion Business Overview
- 4.2.3 Balt Extrusion Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Balt Extrusion Pipeline Embolization Device (PED) Product Portfolio
- 4.2.5 Balt Extrusion Recent Developments
- 4.3 Boston Scientific
- 4.3.1 Boston Scientific Company Information
- 4.3.2 Boston Scientific Business Overview
- 4.3.3 Boston Scientific Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Boston Scientific Pipeline Embolization Device (PED) Product Portfolio
- 4.3.5 Boston Scientific Recent Developments
- 4.4 Codman
- 4.4.1 Codman Company Information
- 4.4.2 Codman Business Overview
- 4.4.3 Codman Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Codman Pipeline Embolization Device (PED) Product Portfolio
- 4.4.5 Codman Recent Developments
- 4.5 Evasc
- 4.5.1 Evasc Company Information
- 4.5.2 Evasc Business Overview
- 4.5.3 Evasc Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Evasc Pipeline Embolization Device (PED) Product Portfolio
- 4.5.5 Evasc Recent Developments
- 4.6 Microvention
- 4.6.1 Microvention Company Information
- 4.6.2 Microvention Business Overview
- 4.6.3 Microvention Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Microvention Pipeline Embolization Device (PED) Product Portfolio
- 4.6.5 Microvention Recent Developments
- 4.7 Phenox GmbH
- 4.7.1 Phenox GmbH Company Information
- 4.7.2 Phenox GmbH Business Overview
- 4.7.3 Phenox GmbH Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Phenox GmbH Pipeline Embolization Device (PED) Product Portfolio
- 4.7.5 Phenox GmbH Recent Developments
- 4.8 Accumedical
- 4.8.1 Accumedical Company Information
- 4.8.2 Accumedical Business Overview
- 4.8.3 Accumedical Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Accumedical Pipeline Embolization Device (PED) Product Portfolio
- 4.8.5 Accumedical Recent Developments
- 4.9 ZYLOX-TONBRIDGE
- 4.9.1 ZYLOX-TONBRIDGE Company Information
- 4.9.2 ZYLOX-TONBRIDGE Business Overview
- 4.9.3 ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Product Portfolio
- 4.9.5 ZYLOX-TONBRIDGE Recent Developments
- 4.10 Medtronic
- 4.10.1 Medtronic Company Information
- 4.10.2 Medtronic Business Overview
- 4.10.3 Medtronic Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Medtronic Pipeline Embolization Device (PED) Product Portfolio
- 4.10.5 Medtronic Recent Developments
- 4.11 Johnson & Johnson
- 4.11.1 Johnson & Johnson Company Information
- 4.11.2 Johnson & Johnson Business Overview
- 4.11.3 Johnson & Johnson Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Johnson & Johnson Pipeline Embolization Device (PED) Product Portfolio
- 4.11.5 Johnson & Johnson Recent Developments
- 4.12 Stryker Corporation
- 4.12.1 Stryker Corporation Company Information
- 4.12.2 Stryker Corporation Business Overview
- 4.12.3 Stryker Corporation Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Stryker Corporation Pipeline Embolization Device (PED) Product Portfolio
- 4.12.5 Stryker Corporation Recent Developments
- 4.13 MicroPort
- 4.13.1 MicroPort Company Information
- 4.13.2 MicroPort Business Overview
- 4.13.3 MicroPort Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 MicroPort Pipeline Embolization Device (PED) Product Portfolio
- 4.13.5 MicroPort Recent Developments
5 Global Pipeline Embolization Device (PED) Market Scenario by Region
- 5.1 Global Pipeline Embolization Device (PED) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pipeline Embolization Device (PED) Sales by Region: 2021-2032
- 5.2.1 Global Pipeline Embolization Device (PED) Sales by Region: 2021-2026
- 5.2.2 Global Pipeline Embolization Device (PED) Sales by Region: 2027-2032
- 5.3 Global Pipeline Embolization Device (PED) Revenue by Region: 2021-2032
- 5.3.1 Global Pipeline Embolization Device (PED) Revenue by Region: 2021-2026
- 5.3.2 Global Pipeline Embolization Device (PED) Revenue by Region: 2027-2032
- 5.4 North America Pipeline Embolization Device (PED) Market Facts & Figures by Country
- 5.4.1 North America Pipeline Embolization Device (PED) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pipeline Embolization Device (PED) Sales by Country (2021-2032)
- 5.4.3 North America Pipeline Embolization Device (PED) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pipeline Embolization Device (PED) Market Facts & Figures by Country
- 5.5.1 Europe Pipeline Embolization Device (PED) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pipeline Embolization Device (PED) Sales by Country (2021-2032)
- 5.5.3 Europe Pipeline Embolization Device (PED) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pipeline Embolization Device (PED) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pipeline Embolization Device (PED) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pipeline Embolization Device (PED) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pipeline Embolization Device (PED) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pipeline Embolization Device (PED) Market Facts & Figures by Country
- 5.7.1 South America Pipeline Embolization Device (PED) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pipeline Embolization Device (PED) Sales by Country (2021-2032)
- 5.7.3 South America Pipeline Embolization Device (PED) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Pipeline Embolization Device (PED) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pipeline Embolization Device (PED) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pipeline Embolization Device (PED) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pipeline Embolization Device (PED) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pipeline Embolization Device (PED) Sales by Type (2021-2032)
- 6.1.1 Global Pipeline Embolization Device (PED) Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Pipeline Embolization Device (PED) Sales Market Share by Type (2021-2032)
- 6.2 Global Pipeline Embolization Device (PED) Revenue by Type (2021-2032)
- 6.2.1 Global Pipeline Embolization Device (PED) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pipeline Embolization Device (PED) Revenue Market Share by Type (2021-2032)
- 6.3 Global Pipeline Embolization Device (PED) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pipeline Embolization Device (PED) Sales by Application (2021-2032)
- 7.1.1 Global Pipeline Embolization Device (PED) Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Pipeline Embolization Device (PED) Sales Market Share by Application (2021-2032)
- 7.2 Global Pipeline Embolization Device (PED) Revenue by Application (2021-2032)
- 7.2.1 Global Pipeline Embolization Device (PED) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pipeline Embolization Device (PED) Revenue Market Share by Application (2021-2032)
- 7.3 Global Pipeline Embolization Device (PED) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pipeline Embolization Device (PED) Value Chain Analysis
- 8.1.1 Pipeline Embolization Device (PED) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pipeline Embolization Device (PED) Production Mode & Process
- 8.2 Pipeline Embolization Device (PED) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pipeline Embolization Device (PED) Distributors
- 8.2.3 Pipeline Embolization Device (PED) Customers
9 Global Pipeline Embolization Device (PED) Analyzing Market Dynamics
- 9.1 Pipeline Embolization Device (PED) Industry Trends
- 9.2 Pipeline Embolization Device (PED) Industry Drivers
- 9.3 Pipeline Embolization Device (PED) Industry Opportunities and Challenges
- 9.4 Pipeline Embolization Device (PED) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst